Last updated on July 2019

Study to Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure


Brief description of study

This study consist of two parts (Part 1 and Part 2). The purpose of Part 1 is to evaluate the way the body absorbs, distributes and removes the drug LCZ696. This will help determine the proper dose of LCZ696 for Part 2 of the study.

The purpose for Part 2 is to compare the effectiveness and safety of LCZ696 with enalapril in pediatric heart failure patients over 52 weeks of treatment.

Clinical Study Identifier: NCT02678312

Find a site near you

Start Over

Novartis Investigative Site

Loma Linda, CA United States
  Connect »

Novartis Investigative Site

Los Angeles, CA United States
  Connect »

Novartis Investigative Site

Palo Alto, CA United States
  Connect »

Novartis Investigative Site

San Diego, CA United States
  Connect »

Novartis Investigative Site

New Haven, CT United States
  Connect »

Novartis Investigative Site

Hollywood, FL United States
  Connect »

Novartis Investigative Site

Atlanta, GA United States
  Connect »

Novartis Investigative Site

Indianapolis, IN United States
  Connect »

Novartis Investigative Site

Ann Arbor, MI United States
  Connect »

Novartis Investigative Site

Minneapolis, MN United States
  Connect »

Novartis Investigative Site

Rochester, MN United States
  Connect »

Novartis Investigative Site

Saint Louis, MO United States
  Connect »

Novartis Investigative Site

New York, NY United States
  Connect »

Novartis Investigative Site

Charlotte, NC United States
  Connect »

Novartis Investigative Site

Cleveland, OH United States
  Connect »

Novartis Investigative Site

Philadelphia, PA United States
  Connect »

Novartis Investigative Site

Salt Lake City, UT United States
  Connect »

Novartis Investigative Site

Seattle, WA United States
  Connect »

Novartis Investigative Site

Seoul, Korea, Republic of
  Connect »

Novartis Investigative Site

Phoenix, AZ United States
  Connect »

Novartis Investigative Site

Gainesville, FL United States
  Connect »

Novartis Investigative Site

Saint Petersburg, FL United States
  Connect »

Novartis Investigative Site

Louisville, KY United States
  Connect »

Novartis Investigative Site

Kansas City, MO United States
  Connect »

Novartis Investigative Site

Cincinnati, OH United States
  Connect »

Novartis Investigative Site

Pittsburgh, PA United States
  Connect »

Novartis Investigative Site

Memphis, TN United States
  Connect »

Novartis Investigative Site

Houston, TX United States
  Connect »

Novartis Investigative Site

Milwaukee, WI United States
  Connect »

Novartis Investigative Site

Ciudad de Salta, Argentina
  Connect »

Novartis Investigative Site

Yangsan Si, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.